AstraZeneca
Bristol Myers Squibb
CStone Therapeutics
GlaxoSmithKline
Immuneering
Merck
NFlection Therapeutics
Novartis
Ono Pharmaceutical
Pfizer
Roche
SpringWorks Therapeutics
Published | Pages | Publisher | Report code |
---|---|---|---|
Oct 2021 | 172 | Kuick Research | ASDR-592189 |
AstraZeneca
Bristol Myers Squibb
CStone Therapeutics
GlaxoSmithKline
Immuneering
Merck
NFlection Therapeutics
Novartis
Ono Pharmaceutical
Pfizer
Roche
SpringWorks Therapeutics